CCM
AVDL

Cutter Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Cutter Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-385,172
Closed -$5.05M – 24
2024
Q3 		$5.05M Sell
385,172
-347,829
-47% -$5.3M 1.49% 26
2024
Q2 		$10.3M Buy
733,001
+191,075
+35% +$3.11M 3.11% 17
2024
Q1 		$9.15M Buy
+541,926
New +$8.07M 3.5% 15

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $370M AUM 97.79% 1-Year Est. Return

Cutter Capital Management's AVDL Position: Q4 2024 in Review

Cutter Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q4 2024, closing a stake of 385,172 shares — an estimated $5.05M sold.

Cutter Capital Management first reported a position in AVDL in Q1 2024 and held it in 3 quarters. The position peaked at $10.3M in Q2 2024. 159 funds tracked by Wall St. Rank hold AVDL as of Q4 2024.

  • Cutter Capital Management reported no remaining Avadel Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Cutter Capital Management sold 385,172 Avadel Pharmaceuticals shares in Q4 2024, an estimated $5.05M.
  • Cutter Capital Management first reported a position in Avadel Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Cutter Capital Management's Avadel Pharmaceuticals position peaked at $10.3M in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2024.

Based on Cutter Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.